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Editorialditorial 
Reconsidering management for 
otitis media with effusion in children
Apart from the common cold, otitis media is the most frequently 
diagnosed illness in a country like the United States with treat-
ment by myringotomy and insertion of tympanoplasty tubes be-
ing the most frequent operation in children beyond the neonatal 
period1,2. The highest rate of occurrence is in the first two years 
of life and, in close agreement with several previous studies, a 
large-scale investigation by Paradise and colleagues1 revealed 
that 48% of infants aged 6 months and 79% of infants aged 
12 months and 91% of infants aged 24 months presented with 
at least one episode of otitis media with effusion (OME). This 
means that nine in every ten children at the age of two years 
have had at least one episode of OME which can be transient 
or can persist for several months. These figures may be even 
higher in a developing country like South Africa with large sec-
tions of disadvantaged communities since OME has been asso-
ciated with poor socioeconomic circumstances.
Until recently, guidelines for intervention in OME for children 
recommended minimizing the possible effects on developmen-
tal outcomes due to the mild conductive hearing loss caused by 
OME by prompt insertion of tympanostomy tubes in infants and 
young children presenting with persistent middle-ear effusion 
(MEE) for more than 3 to 4 months1.  Since evidence regarding 
the effects of a conductive loss due to OME in young children 
was inconclusive and a dearth of evidence indicating a favour-
able effect on development due to insertion of tympanostomy 
tubes resided, a large scale clinical trial was initiated in 1991 by 
Paradise and colleagues. 
The longitudinal clinical trial by Paradise and colleagues en-
rolled a large cohort of healthy infants whose middle-ear sta-
tus was monitored at least monthly until 3 years of age. The ran-
domisation was between infants with persistent MEE who re-
ceived prompt insertion of tympanostomy tubes and those re-
ceiving tympanostomy tubes 6 months later for bilateral MEE 
and 9 months later for unilateral MEE. Extensive developmen-
tal assessments were conducted at 3, 6, and 9 to 11 years of 
age. The results were published in 2001, 2005 and 2007 for de-
velopmental outcomes at 3, 6 and 9 to 11 years of age, respec-
tively2,3,4.
These reports indicated that early tympanostomy tube 
placement compared to delayed tube placement in the chil-
dren with persistent MEE did not result in a significant effect on 
developmental outcomes up to 9 to 11 years of age. The devel-
opmental areas assessed at the various age intervals included 
cognitive, language, speech, phonological, and psychosocial 
development as well as measures of literacy, attention, audito-
ry processing skills, social skills, and academic achievement. 
The consistency of these findings by Paradise et al. provides 
convincing evidence, in contrast to many previously held con-
victions, that OME does not cause developmental impairments 
and prompt insertion of tympanostomy tubes does not therefore 
improve developmental outcomes up to 9 to 11 years of age in 
otherwise healthy newborns2,3,4. 
Limitations of the trial must, however, be acknowledged be-
fore findings are generalised. The study was conducted on 
healthy newborns and cannot be generalised to children with 
additional risk factors, such as language or other developmen-
tal delays, and the possible favourable effect of prompt tympa-
nostomy insertion in such cases. In addition to this the study in-
cluded very few cases with hearing loss reaching 40 decibels 
(dB) or more due to OME and therefore could not address the 
question of whether this degree of loss may lead to impairments 
in developmental outcomes.
As a result of these and other corroborating findings the 
guideline for treatment of OME was revised jointly by the Amer-
ican Academy of Family Physicians, the American Academy 
of Otolaryngology-Head and Neck Surgery, and the American 
Academy of Pediatrics5. The revised approach to intervention 
for persistent MEE is now more conservative leaving the risk of 
surgery and anaesthesia for insertion of tympanostomy tubes 
as a last resort. Recommendations include follow-up visits for 
determining the laterality and duration of the effusion and the 
risk of speech, language, or learning difficulties not related to 
otitis media. In otherwise normal children a hearing test must 
be performed if the effusion persists for 3 months and must be 
continually monitored at 3- to 6-month intervals until either a bi-
lateral hearing loss of 40 dB or higher is documented, a speech 
or language delay is diagnosed, a structural abnormality of the 
eardrum develops, in which case the surgical placement of 
tympanostomy tubes is recommended. Prescription of antihis-
tamines, decongestants, antimicrobials and corticosteroids are 
not recommended for routine management of OME due to poor 
long-term efficacy and the growing concern of increasing mi-
crobial resistance5,6.  
The conservative treatment recommended for OME in chil-
dren may ultimately result in significant healthcare savings for 
South Africa in terms of surgery and medication costs currently 
allocated to the management of this prevalent condition. Care 
must however be taken to diligently monitor children with OME 
within a collaborative team approach including the family physi-
cian, paediatrician, otolaryngologist, audiologists and speech-
language therapist to ensure developmental outcomes are not 
compromised due to poor surveillance. 
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